CORT – corcept therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Corcept Therapeutics Incorporated (CORT) Modifies Revenue Guidance while Banking on Cushing Syndrome Treatment for Growth [Yahoo! Finance]
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Corcept Therapeutics (NASDAQ:CORT) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Corcept Therapeutics (NASDAQ:CORT) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Corcept (NASDAQ:CORT) [Yahoo! Finance]
Form 4 CORCEPT THERAPEUTICS For: Dec 01 Filed by: Guyer William
Form 4 CORCEPT THERAPEUTICS For: Dec 01 Filed by: Maduck Sean
Form 4 CORCEPT THERAPEUTICS For: Dec 01 Filed by: Lyon Joseph Douglas
Form 4 CORCEPT THERAPEUTICS For: Dec 01 Filed by: Mokari Atabak
Form 4 CORCEPT THERAPEUTICS For: Dec 01 Filed by: Robb Gary Charles
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.